FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292372811> ?p ?o ?g. }

• W4292372811 abstract "With the clinical approval of T-cell–dependent immune checkpoint inhibitors for many cancers, therapeutic cancer vaccines have re-emerged as a promising immunotherapy. Cancer vaccines require the addition of immunostimulatory adjuvants to increase vaccine immunogenicity, and increasingly multiple adjuvants are used in combination to bolster further and shape cellular immunity to tumor antigens. However, rigorous quantification of adjuvants’ synergistic interactions is challenging due to partial redundancy in costimulatory molecules and cytokine production, leading to the common assumption that combining both adjuvants at the maximum tolerated dose results in optimal efficacy. Herein, we examine this maximum dose assumption and find combinations of these doses are suboptimal. Instead, we optimized dendritic cell activation by extending the Multidimensional Synergy of Combinations (MuSyC) framework that measures the synergy of efficacy and potency between two vaccine adjuvants. Initially, we performed a preliminary in vitro screening of clinically translatable adjuvant receptor targets (TLR, STING, NLL, and RIG-I). We determined that STING agonist (CDN) plus TLR4 agonist (MPL-A) or TLR7/8 agonist (R848) as the best pairwise combinations for dendritic cell activation. In addition, we found that the combination of R848 and CDN is synergistically efficacious and potent in activating both murine and human antigen-presenting cells (APCs) in vitro . These two selected adjuvants were then used to estimate a MuSyC-dose optimized for in vivo T-cell priming using ovalbumin-based peptide vaccines. Finally, using B16 melanoma and MOC1 head and neck cancer models, MuSyC-dose–based adjuvating of cancer vaccines improved the antitumor response, increased tumor-infiltrating lymphocytes, and induced novel myeloid tumor infiltration changes. Further, the MuSyC-dose–based adjuvants approach did not cause additional weight changes or increased plasma cytokine levels compared to CDN alone. Collectively, our findings offer a proof of principle that our MuSyC-extended approach can be used to optimize cancer vaccine formulations for immunotherapy." @default.
• W4292372811 created "2022-08-20" @default.
• W4292372811 creator A5003212140 @default.
• W4292372811 creator A5029542971 @default.
• W4292372811 creator A5033246668 @default.
• W4292372811 creator A5035444040 @default.
• W4292372811 creator A5037982412 @default.
• W4292372811 creator A5042876716 @default.
• W4292372811 creator A5044134935 @default.
• W4292372811 creator A5045924302 @default.
• W4292372811 creator A5050186959 @default.
• W4292372811 creator A5065906584 @default.
• W4292372811 creator A5070022616 @default.
• W4292372811 creator A5077831597 @default.
• W4292372811 creator A5080912865 @default.
• W4292372811 creator A5091328725 @default.
• W4292372811 date "2022-08-19" @default.
• W4292372811 modified "2023-10-16" @default.
• W4292372811 title "MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses" @default.
• W4292372811 cites W1544940894 @default.
• W4292372811 cites W1603862958 @default.
• W4292372811 cites W1673416641 @default.
• W4292372811 cites W1877493092 @default.
• W4292372811 cites W1970914652 @default.
• W4292372811 cites W1972570108 @default.
• W4292372811 cites W1991148746 @default.
• W4292372811 cites W1992915380 @default.
• W4292372811 cites W2018325317 @default.
• W4292372811 cites W2038403177 @default.
• W4292372811 cites W2039123767 @default.
• W4292372811 cites W2073423503 @default.
• W4292372811 cites W2084276469 @default.
• W4292372811 cites W2085342350 @default.
• W4292372811 cites W2099263305 @default.
• W4292372811 cites W2101638490 @default.
• W4292372811 cites W2102886314 @default.
• W4292372811 cites W2105088577 @default.
• W4292372811 cites W2108362630 @default.
• W4292372811 cites W2115542848 @default.
• W4292372811 cites W2122855649 @default.
• W4292372811 cites W2140715248 @default.
• W4292372811 cites W2148482462 @default.
• W4292372811 cites W2149868081 @default.
• W4292372811 cites W2159059319 @default.
• W4292372811 cites W2159773858 @default.
• W4292372811 cites W2272228147 @default.
• W4292372811 cites W2324902637 @default.
• W4292372811 cites W2517416985 @default.
• W4292372811 cites W2539792908 @default.
• W4292372811 cites W2561974317 @default.
• W4292372811 cites W2606192673 @default.
• W4292372811 cites W2626019299 @default.
• W4292372811 cites W2747769029 @default.
• W4292372811 cites W2785869969 @default.
• W4292372811 cites W2790641321 @default.
• W4292372811 cites W2803462995 @default.
• W4292372811 cites W2805147383 @default.
• W4292372811 cites W2809886276 @default.
• W4292372811 cites W2905184569 @default.
• W4292372811 cites W2909554490 @default.
• W4292372811 cites W2917986762 @default.
• W4292372811 cites W2922342052 @default.
• W4292372811 cites W2926877280 @default.
• W4292372811 cites W2944255077 @default.
• W4292372811 cites W2944427520 @default.
• W4292372811 cites W3007118752 @default.
• W4292372811 cites W3012160408 @default.
• W4292372811 cites W3012223268 @default.
• W4292372811 cites W3095380508 @default.
• W4292372811 cites W3095906253 @default.
• W4292372811 cites W3112902030 @default.
• W4292372811 cites W3183139760 @default.
• W4292372811 cites W3185504912 @default.
• W4292372811 cites W3210892875 @default.
• W4292372811 cites W3216713979 @default.
• W4292372811 doi "https://doi.org/10.3389/fimmu.2022.936129" @default.
• W4292372811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36059502" @default.
• W4292372811 hasPublicationYear "2022" @default.
• W4292372811 type Work @default.
• W4292372811 citedByCount "1" @default.
• W4292372811 countsByYear W42923728112023 @default.
• W4292372811 crossrefType "journal-article" @default.
• W4292372811 hasAuthorship W4292372811A5003212140 @default.
• W4292372811 hasAuthorship W4292372811A5029542971 @default.
• W4292372811 hasAuthorship W4292372811A5033246668 @default.
• W4292372811 hasAuthorship W4292372811A5035444040 @default.
• W4292372811 hasAuthorship W4292372811A5037982412 @default.
• W4292372811 hasAuthorship W4292372811A5042876716 @default.
• W4292372811 hasAuthorship W4292372811A5044134935 @default.
• W4292372811 hasAuthorship W4292372811A5045924302 @default.
• W4292372811 hasAuthorship W4292372811A5050186959 @default.
• W4292372811 hasAuthorship W4292372811A5065906584 @default.
• W4292372811 hasAuthorship W4292372811A5070022616 @default.
• W4292372811 hasAuthorship W4292372811A5077831597 @default.
• W4292372811 hasAuthorship W4292372811A5080912865 @default.
• W4292372811 hasAuthorship W4292372811A5091328725 @default.
• W4292372811 hasBestOaLocation W42923728111 @default.
• W4292372811 hasConcept C121608353 @default.
• W4292372811 hasConcept C126322002 @default.
• W4292372811 hasConcept C136449434 @default.

• next